Elanco: Past, Present and Future

Since our start, Elanco has worked to empower veterinarians, farmers, and all those caring for animals with the tools needed to help animals live healthy lives.


A Legacy of Innovation

For nearly 70 years, we've focused on delivering innovative animal health solutions that solve our customers’ greatest challenges.

1950-1989

Where it All Began

Elanco has helped shape the lives of animals and their care providers for more than half a century.

1953

The Beginning of Elanco Animal Health

Eli Lilly and Company introduces the first antibiotic exclusively for veterinary use.

lilly elanco building

1955

Agricultural and Veterinary Medicine Research Center

Eli Lilly and Company purchases acreage adjoining the Biological Laboratories of Greenfield, Ind. The facility is completed in 1959 and opens as the Agricultural and Veterinary Medicine Research Center.

1956

Expanding Products

With the purchase of Corn State Laboratories, Lilly expands its line of veterinary products.

1960

Growing Rapidly

In 1960, Elanco began growing rapidly into new countries and markets.

1970s

Growing Business and Products

Elanco continues its global expansion and changes its identity with a bold new logo.

1980s

New Research Focus

Research and development shifts from plant science toward animal health, specifically on increasing the quality of animal-sourced protein.

1990-2000

2000-2010

2007

Bringing Employees Together

Elanco builds a dedicated global headquarters campus in Greenfield, Ind., bringing together employees from all areas of the company for the first time.

2007

Growing Through Acquisition

Elanco launches Companion Animal parasiticides and acquires long-term partner Ivy Animal Health and launches its Pet Animal businesses.

a dog in the vet's office with little boy by its side

2007

Elanco adds Monsanto Dairy Business

Dairy cows in a dairy barn

2011-2020

2010

European Expansion

Expands European business: Pfizer vaccines

2011

Elanco acquires Janssen Animal Health.

2012

A Growing Portfolio

With the acquisition of ChemGen, Elanco obtains a portfolio of feed enzyme products for poultry, egg and meat production.

2013

Global Growth and Product Expansion

Elanco's Pet portfolio grows and en

vet checking out a small dog

2014

Global Poultry Leader

Elanco acquires Lohmann Animal Health and becomes a global leader in poultry.

close up of a chicken

2015

Leading Animal Health

Elanco acquires Novartis Animal Health. The combined organization is committed to leading the animal health industry in delivering innovation and customer value.

Image of Elanco's headquaters sign outside

2016

U.S. Expansion

Elanco expands its U.S. pet health portfolio by acquiring an innovative platform of vaccines from Boehringer Ingelheim Vetmedica.

2018

The New, Independent Elanco

Elanco lists on the New York Stock Exchange (NYSE:ELAN), separating from Lilly and giving its employees ownership.

group of people infront of Elancos office logo clapping and punching the air

2019

Elanco's Healthy Purpose™

Elanco launches its Healthy Purpose™ initiative: its corporate social responsibility platform, and commitment to realizing its vision of Food and Companionship Enriching Life.

Health Purpose icon

Elanco Foundation

Elanco establishes the Elanco Foundation, which is the first-ever charitable foundation in animal health.

Elanco animal health foundation logo

Elanco Completes Separation from Lilly

Elanco becomes a fully-independent pure play animal health company.

girl holding a dog with cattle in the background

2020

Elanco Closes Acquisition of Bayer Animal Health

Elanco, now with the addition of Bayer Animal Health, has improved capabilities, scale and global reach to position the company as a long-term leader in the growing global animal health market.

woman with two dogs during sunrise

2021 to date

2021

ESG Summary Report

Elanco releases its first independent ESG Summary Report

Building a healthy enterprise and driving sustainability are essential to our success and leadership in animal health.

Todd Young, executive vice president and CFO

Elanco closes acquisition of Kindred Biosciences

The transaction advances Elanco’s access to the fast-growing $1+ billion dermatology market, complementing the company’s existing pipeline and increasing R&D capability in biologics and monoclonal antibodies.

Elanco Closes Acquisition of Kindred Biosciences

Animals are the Answer

Sustainable Solutions for Zero Hunger by 2030: A Vision for Animal Agriculture Forum to explore solutions to combat climate change while keeping the world nourished.

The animal protein industry and global leaders convened to highlight the role animals can play in nourishing the population and curbing climate change.

Elanco Selected for 2021 FORTUNE’s Change the World List

FORTUNE's list recognizes companies that have made an important social or environmental impact through their profit-making strategy and operations.

Elanco logo on top of a globe

2022

MAHABA (Managing Animal Health and Acaricides for a Better Africa)

Elanco Expands Commitment to Creating Shared Value, Launches New Initiative Empowering Small-Scale Producers in Sub-Saharan Africa

Elanco and Ginkgo Bioworks Launch BiomEdit

A new Animal Health Company Leveraging Microbiome Technology

Elanco Breaks Ground on new Headquarters

Elanco Breaks Ground on State-of-the-Art Campus, Creating Indianapolis’ Newest Landmark

Rendering of Elanco's new HQ

You Might Be Interested In

Get to know Elanco, our hiring process and our people’s contributions to the well-being of animals.

two males knelt down making something out of bamboo

Purpose-Driven Culture

Learn how we foster a culture that's driven by values and celebrates our company purpose.

three men and a woman smiling at the camera sat at a desk

Our People

Read about the individuals who shape Elanco and bring our culture and values to life.

man and woman talking at a table in Elanco office

Our Initiatives

See how we advance our vision of Food and Companionship Enriching Life through participation in programs and community projects.


Connect with Elanco

Country selector

Elanco's Healthy Purpose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2024 Elanco or its affiliates.
EM-GLB-CA-20-0041